Logo-bi
Original Research
Masood Pezeshkian*, Mohammad-Reza Mahtabipour
Bioimpacts. 2013;3(2): 83-89. doi: 10.5681/bi.2013.004
PMCID: PMC3713874     PMID: 23878791     Scopus ID: 84881496124    
PDF
XML
Cited By:
Review
Saghir Akhtar*, Ibrahim Fadil Benter
Bioimpacts. 2013;3(1): 5-9. doi: 10.5681/bi.2013.008
PMCID: PMC3648911     PMID: 23678464     Scopus ID: 84876693184    
PDF
XML
Cited By:
Original Research
Majid Mohammad-Shahi, Masoud Veissi, Fatemeh Haidari, Hajieh Shahbazian, Gholam-Abas Kaydani, Fatemeh Mohammadi*
Bioimpacts. 2014;4(2): 83-88. doi: 10.5681/bi.2014.007
PMCID: PMC4097976     PMID: 25035851     Scopus ID: 84905465316    
Original Research
Mohammad Ali Ghaffari*, Saeed Askari Sede*, Nadereh Rashtchizadeh, Ghorban Mohammadzadeh, Shahla Majidi
Bioimpacts. 2014;4(3): 133-139. doi: 10.15171/bi.2014.006
PMCID: PMC4204038     PMID: 25337466     Scopus ID: 84908210577    
PDF
XML
Cited By:
Short Communication
Pavan Kumar Bellamakondi*, Ashok Godavarthi, Mohammed Ibrahim
Bioimpacts. 2014;4(3): 113-116. doi: 10.15171/bi.2014.003
PMCID: PMC4204035     PMID: 25337463     Scopus ID: 84908211789    
PDF
XML
Cited By:
Original Research
Himan Heidari, Mohammad Kamalinejad, Maryam Noubarani, Mokhtar Rahmati, Iman Jafarian, Hasan Adiban, Mohammad Reza Eskandari*
Bioimpacts. 2016;6(1): 33-39. doi: 10.15171/bi.2016.05
PMCID: PMC4916550     PMID: 27340622     Scopus ID: 84977156856    
Original Research
Mohammad Reza Ranjouri, Parisa Aob, Sima Mansoori Derakhshan, Mahmoud Shekari Khaniani, Hossein Chiti, Ali Ramazani*
Bioimpacts. 2016;6(4): 187-193. doi: 10.15171/bi.2016.25
PMCID: PMC5326666     PMID: 28265534     Scopus ID: 85013115080    
Original Research
Tayibeh Ghaffari, Mohammad Nouri, Ebrahim Irannejad, Mohammad-Reza Rashidi*
Bioimpacts. 2011;1(2): 121-128. doi: 10.5681/bi.2011.016
PMCID: PMC3648954     PMID: 23678416     Scopus ID: 84876727962    
PDF
XML
Cited By:
Original Research
Navid Hosseini Mansoub*, Mehmet Gürdal, Elif Karadadaş, Hilal Kabadayi, Seda Vatansever, Gulinnaz Ercan
Bioimpacts. 2018;8(1): 5-12. doi: 10.15171/bi.2018.02
PMCID: PMC5915708     PMID: 29713597     Scopus ID: 85044304206    
Original Research
Shahin Alizadeh-Fanalou ORCID, Ali Nazarizadeh ORCID, Mohammad Babaei ORCID, Mohsen Khosravi ORCID, Navid Farahmandian, Elham Bahreini* ORCID
Bioimpacts. 2020;10(3): 159-167. doi: 10.34172/bi.2020.20
PMCID: PMC7416011     PMID: 32793438     Scopus ID: 85089710918    
Glibenclamide was more effective than the highest dose of Securigera securidaca seed extract inincreasing PON1 activity, but the extract was more effective than glibenclamide in decreasing lipidperoxidation and cardiovascular risk indices.
Original Research
Mohammad Ghader Bayazidi, Reza Rahbarghazi ORCID, Aysa Rezabakhsh ORCID, Jafar Rezaie ORCID, Mehdi Hassanpour, Mahdi Ahmadi* ORCID
Bioimpacts. 2023;13(1): 43-50. doi: 10.34172/bi.2022.22183
PMCID: PMC9923816     PMID: 36817001     Scopus ID: 36817001    
This study aimed to investigate the effect of type 2 diabetic condition on autophagy status in lung tissue of male rats. The possible relationship between autophagy and inflammation was also monitored.
Original Research
Fatemeh Karami ORCID, Behrouz Asgari Abibeiglou, Saghar Pahlavanneshan, Ali Farrokhi, Amin Tamadon, Mohsen Basiri, Keynoosh Khalooghi, Majid Fallahi, Yaser Tahamtani* ORCID
BioImpacts. 2022;12(5): 463-470. doi: 10.34172/bi.2022.23840
PMCID: PMC9596880     PMID: 36381631     Scopus ID: 85140264417    
miR-21 overexpression can result in down-regulation of the critical inhibitory proteins in tumor cells. Anti-miR-21 delivery to resistant ovary tumor cells using the carboxymethylated PEG5k-polyethylenemine nanohydrogels bearing redox-sensitive crosslinks, knockdown the tumor associated 669 angiogenesis and provoke apoptosis though ROS generation.
Original Article
Zahra Bahadoran ORCID, Parvin Mirmiran, Fereidoun Azizi, Asghar Ghasemi* ORCID
Bioimpacts. 2024;. doi: 10.34172/bi.2024.29917
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge